Business Insider: “The FDA just published a list of drug makers the agency says are using “gaming” tactics to keep generic competition off the market. The list of 52 drugs are made by some of the biggest pharmaceutical companies including Novartis, Pfizer, Mylan, and Valeant “FDA is committed – among other things – to addressing and improving transparency about this and other gaming tactics that delay the generic competition Congress intended,” the agency said on Thursday. [h/t Pete Weiss]

• The list, which the FDA said will be updated semi-annually, names 39 major pharmaceutical and biotech companies who the agency says make it hard for generic competitors to get samples of their drugs…”